Arnold C. Hanish

This profile gathers the share dealings of Arnold C. Hanish across 3 companies, led by ELI LILLY & Co, Salarius Pharmaceuticals, Inc. and Omeros Corp. Between 20 January 2006 and 27 August 2026, the trades on record add up to 45 filings.

On the open market, the record shows 11 purchases worth €67k and 11 sales worth €594k. Netting one side against the other leaves €527k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 11 share grants and 7 option exercises. 2026 to date brings no purchases and 5 sales.

In size, the median ticket on the buying side is €4,792. Of 7 purchases, 4 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The newest entry dates from 28 August 2026: an option exercise of €68k, in Omeros Corp. The clock since the last published purchase (24 November 2025) now reads 334 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.